KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $707.2 million.

  • Fulgent Genetics' Non-Current Assets fell 2204.91% to $707.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 billion, marking a year-over-year decrease of 536.25%. This contributed to the annual value of $866.4 million for FY2024, which is 1909.46% up from last year.
  • Fulgent Genetics' Non-Current Assets amounted to $707.2 million in Q3 2025, which was down 2204.91% from $771.1 million recorded in Q2 2025.
  • Fulgent Genetics' 5-year Non-Current Assets high stood at $907.2 million for Q3 2024, and its period low was $339.9 million during Q1 2021.
  • For the 5-year period, Fulgent Genetics' Non-Current Assets averaged around $731.7 million, with its median value being $771.1 million (2025).
  • Per our database at Business Quant, Fulgent Genetics' Non-Current Assets soared by 102548.75% in 2021 and then tumbled by 2204.91% in 2025.
  • Over the past 5 years, Fulgent Genetics' Non-Current Assets (Quarter) stood at $666.8 million in 2021, then increased by 13.71% to $758.2 million in 2022, then decreased by 4.05% to $727.5 million in 2023, then increased by 19.09% to $866.4 million in 2024, then decreased by 18.38% to $707.2 million in 2025.
  • Its Non-Current Assets was $707.2 million in Q3 2025, compared to $771.1 million in Q2 2025 and $789.0 million in Q1 2025.